Back
ESC Premium Access

Anti-platelet effect of intravenous P2Y12 receptor inhibitor cangrelor is not influenced by reticulated platelets

Session: Remaining in the spotlight: antiplatelet agents
Topic: Drug therapy
Speaker: Doctor C. Stratz (Bad Krozingen, DE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Christian Stratz

University Heart Centre Freiburg-Bad Krozingen, Bad Krozingen (Germany)
0 follower

6 more presentations in this session

Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (nhis)

Speaker: Ms S. Kang (Busan, KR)

Access
Abstract
Slides
Like
Thumbnail

Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access
Abstract
Slides
Like
Thumbnail

The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials

Speaker: Mr G. Wolff (Ibbenbüren, DE)

Access
Abstract
Slides
Like
Thumbnail

Antiplatelet therapy and adverse outcomes in high cardiovascular risk elderly patients: a sex and gender focused analysis from REPOSI study

Speaker: Doctor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Remaining in the spotlight: antiplatelet agents

Speakers: Doctor C. Stratz, Ms S. Kang, Doctor M. Esteve Pastor, Mr W. Liu, Mr G. Wolff...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources